As a weathervane of China Biotech, CES HK Biotechnology Index (CES HK Biotech) roseby 9.51% in January, By comparison, A-shares of the China Securities Medicine Index has been rising at 5.02%, the Shanghai and Shenzhen 300 Index had a growth rate at 2.7% and the Hang Seng Index (HSI) had a 3.87% growth.
Further
information
PharmaDJ
花旗环球金融的分析师认为,2021年种国医药行业将欣欣向荣的复苏。
Further
information
投资
环孢素A眼凝胶是公司自主研发的核心产品之一,也是最有潜力进入市场的一款产品。
Further
information
分析
计划在今年一季度分别在中美两地提交普那布林上市申请。
Further
information
大话JPM
将尽快启动GB491在中国的针对HR+/HER2-转移性及早期乳腺癌及其他适应症的临床开发。
Further
information
大话JPM
管线中将提交超过6个生物药和8个小分子新药申请,及10-15个新单抗和双抗的中美双报。
Further
information
大话JPM
创响有志于引领Global Partnering 2.0 的大潮。
Further
information
江湖
有17年罕见病研发经验的朱云祥挂帅北海康成全球研究副总裁。
Further
information
江湖